February 10, 2020

Peanut allergy is a condition that can result in severe, life-threatening reactions. These allergic reactions occur in peanut-sensitive individuals when the body mistakes a peanut for a harmful invader. Recently, the FDA approved a new treatment called Palforzia (Peanut Allergen Powder) to reduce severity of reactions in the case of accidental exposure to peanuts. It is approved for children ages 4 – 17. The oral immunotherapy involves an initial dose, followed by a phase of up-dosing over a few months, and ultimately a maintenance phase. Because Palforzia contains peanut allergen, it is important that these doses be administered by a healthcare professional prepared to manage severe reactions, including anaphylaxis.

The Asthma Center will now offer oral peanut desensitization therapy, in addition to sensitivity evaluations for all foods. Although Palforzia does not cure peanut allergy, studies have shown that it effectively reduces risk of severe allergic reaction, and it may be an appropriate treatment for your child. Contact us to schedule an evaluation or learn more about this treatment option.

The health information contained in this article is meant for basic informational purposes only. It is not intended to serve as medical advice, substitute for a doctor’s appointment or to be used for diagnosing or treating a disease.